Cédric Eichmann

Cédric Eichmann

Auto-generated profile, based on publicly available information

Cédric Eichmann

In-Cell NMR Laboratory, Department of NMR-supported Structural Biology, Leibniz Institute of Molecular Pharmacology (FMP Berlin), Robert-Rössle Straße 10, 13125 Berlin, Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2018 in Science
Verified
Journal Article
Open access
PDF file
GYGavin Young
Gavin Young
NHNikolas Hundt
Nikolas Hundt
DCDaniel Cole
Daniel Cole
AFAdam Fineberg
Adam Fineberg
JAJoanna Andrecka
Joanna Andrecka
PKPhilipp Kukura
Philipp Kukura
Watching proteins' weight: Careful measurements of light scattering can provide information on individual macromolecules and complexes. Young et al. used a light-scattering approach for accurate mass determination of proteins as small as 20 kDa (see the Perspective by Lee and Klenerman). Movies of protein complex association and dissociation were analyzed to extract biophysical parameters from single molecules and assemblies without labeling. Using this approach, the authors determined in vitro kinetics of fibril and aggregate growth and association constants for a complex protein-glycoprotein assembly. Science , this issue p. 423 ; see also p. 378

9 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PKPratibha Kumari
Pratibha Kumari
DGDhiman Ghosh
Dhiman Ghosh
AVAgathe Vanas
Agathe Vanas
YFYanick Fleischmann
Yanick Fleischmann
TWThomas Wiegand
Thomas Wiegand
CECédric Eichmann
Cédric Eichmann
Significance: The characteristic feature of Parkinson’s disease is the deposition of α-synuclein into insoluble amyloid fibrils. The so-called secondary nucleation mechanism appears to be key for the aggregation kinetics, because binding of monomers on the fibril surface can autocatalytically induce new amyloid seeds. We show by nuclear magnetic and electron paramagnetic resonance spectroscopy that α-synuclein monomer–fibril binding is primarily mediated by transient electrostatic interactions. These intermolecular contacts result in an unfolding of the loosely packed α-synuclein structures and expose the otherwise protected aggregation-prone non-amyloid-β component of the protein. Our data demonstrate that intramolecular unfolding of α-synuclein is a prerequisite for protein aggregation that leads to rapid multiplication of α-synuclein amyloid fibrils via the secondary nucleation process.

26 December 2016 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
SBStefan Bibow
Stefan Bibow
YPYevhen Polyhach
Yevhen Polyhach
CECédric Eichmann
Cédric Eichmann
CCCelestine N Chi
Celestine N Chi
JKJulia Kowal
Julia Kowal
RRRoland Riek
Roland Riek

14 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
QCQi Chen
Qi Chen
MPMarguerite Prior
Marguerite Prior
RDRichard Dargusch
Richard Dargusch
ARAmanda Roberts
Amanda Roberts
RRRoland Riek
Roland Riek
DSDavid Schubert
David Schubert
Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (Aß) that mediates familial Alzheimer's disease pathology. However, given that age is the greatest risk factor for AD, we explored an alternative drug discovery scheme that is based upon efficacy in multiple cell culture models of age-associated pathologies rather than exclusively amyloid metabolism. Using this approach, we identified an exceptionally potent, orally active, neurotrophic molecule that facilitates memory in normal rodents, and prevents the loss of synaptic proteins and cognitive decline in a transgenic AD mouse model.

3 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CECédric Eichmann
Cédric Eichmann
SPSteffen Preissler
Steffen Preissler
Roland RiekRoland Riek
Roland Riek
EDElke Deuerling
Elke Deuerling
The folding of proteins in living cells may start during their synthesis when the polypeptides emerge gradually at the ribosomal exit tunnel. However, our current understanding of cotranslational folding processes at the atomic level is limited. We employed NMR spectroscopy to monitor the conformation of the SH3 domain from α-spectrin at sequential stages of elongation via in vivo ribosome-arrested 15 N, 13 C-labeled nascent polypeptides. These nascent chains exposed either the entire SH3 domain or C-terminally truncated segments thereof, thus providing snapshots of the translation process. We show that nascent SH3 polypeptides remain unstructured during elongation but fold into a compact, native-like β -sheet assembly when the entire sequence information is available. Moreover, the ribosome neither imposes major conformational constraints nor significantly interacts with exposed unfolded nascent SH3 domain moieties. Our data provide evidence for a domainwise folding of the SH3 domain on ribosomes without significant population of folding intermediates. The domain follows a thermodynamically favorable pathway in which sequential folding units are stabilized, thus avoiding kinetic traps during the process of cotranslational folding.

20 May 2012 in Nature Methods
Verified
Journal Article
Closed access
PDF file
CKChristian Klammt
Christian Klammt
IMInnokentiy Maslennikov
Innokentiy Maslennikov
MBMonika Bayrhuber
Monika Bayrhuber
CECédric Eichmann
Cédric Eichmann
NVNavratna Vajpai
Navratna Vajpai
SCSenyon Choe
Senyon Choe